ClinicalTrials.Veeva

Menu

Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

P

Pediatric Clinical Research Platform

Status

Enrolling

Conditions

Wounds and Injuries

Treatments

Device: Absorbable
Device: Non absorbable

Study type

Interventional

Funder types

Other

Identifiers

NCT02777346
CER 09-057

Details and patient eligibility

About

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

Outcomes are:

  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Full description

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

After obtaining the patient's/parent's consent and randomization, the suture material will be provided.

Selection of the size of the thread and the date of the first follow-up are determined as follows:

  • Face: Thread size 5-0 to 7-0, first follow-up 4-7 days
  • Torso/back: Thread size 4-0 or 5-0, first follow-up 10-14 days
  • Arms: Thread size 4-0 or 5-0, first follow-up 7- 10 days
  • Hand: Thread size 5-0 or 6-0, first follow-up 7-10 days
  • Legs: Thread size 4-0 or 5-0, first follow-up 7-14 days

The patients are examined by in the outpatient wound clinic by specialised nurses under medical supervision at the first follow-up, and at six months by one of the investigators.

Outcomes:

  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Enrollment

500 estimated patients

Sex

All

Ages

1 day to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient younger than 16 years of age with a wound requiring suture

Exclusion criteria

  • Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.)
  • Wounds with tissue loss
  • Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.)
  • Wounds caused by animal or human bites
  • Sutures not performed in the emergency room
  • Heavily soiled wounds

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

500 participants in 2 patient groups

Absorbable
Experimental group
Description:
Suture material: Polyglactin 910 thread (Vicryl Rapide®, Ethicon Inc).
Treatment:
Device: Absorbable
Non Absorbable
Active Comparator group
Description:
Suture material: Polypropylene thread (Prolene®, Ethicon Inc).
Treatment:
Device: Non absorbable

Trial contacts and locations

1

Loading...

Central trial contact

Giorgio La Scala, MD PD; Catherine Jorgensen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems